Dicerna Pharmaceuticals Competitors and Similar CompaniesClear all
Dicerna Pharmaceuticals's competitors and similar companies include ImmunityBio.
 Dicerna Pharmaceuticals Dicerna Pharmaceuticals is a clinical-stage biopharmaceutical company that focuses on the discovery and development of treatments for rare inherited diseases. |  ImmunityBio ImmunityBio (formerly known as NantKwest) is a clinical-stage immunotherapy company focused on harnessing the power of the immune system using natural killer cells to treat cancer, infectious diseases, and inflammatory diseases. | |
Founding Date | Founding Date 2007 | Founding Date 2014 |
Type | Type Subsidiary | Type Public |
Tags | ||
Locations | Locations Cambridge, US HQ Boulder, US Lexington, US | Locations Culver City, US HQ San Diego, US Woburn, US |
Employees | Employees 1042% decrease | Employees 16116% increase |
Financial | ||
Revenue (est.) | Revenue (est.) $164.3m (FY, 2020) | Revenue (est.) $113.3m (FY, 2025) |
Net income | Net income ($112.7m) (FY, 2020) | Net income ($351.5m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
ImmunityBio
HQ
Culver City, US
Employees
161↑ 16% increase
ImmunityBio (formerly known as NantKwest) is a clinical-stage immunotherapy company focused on harnessing the power of the immune system using natural killer cells to treat cancer, infectious diseases, and inflammatory diseases.
View company